How best to manage gastrointestinal stromal tumor

doi:10.5306/wjco.v8.i2.135

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8883)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

534

WORD

339

HTML

3507

Figures (1-1)

170

Sum=4550

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

886

Download

1486

Sum=2372

Publishing Process of This Article

Item

Count

Browse

903

Download

1058

Sum=1961

Apr 10, 2017 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Apr 10, 2017; 8(2): 135-144
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.135

Open in New Tab Full Size Figure Download Figure

Figure 1 Pathogenesis. GIST: Gastrointestinal stromal tumor; PDGFRA: Platelet derived growth factor receptor-alpha; HIF: Hypoxia inducible factors.

Citation: Lanke G, Lee JH. How best to manage gastrointestinal stromal tumor. World J Clin Oncol 2017; 8(2): 135-144
URL: https://www.wjgnet.com/2218-4333/full/v8/i2/135.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i2.135